Biostatistics Associate Director (HYBRID)

Scorpion Therapeutics; Boston (MA); Hybrid; USD 180,000 - 240,000; Full time

Benefits offered by this job

Hybrid work model

Flexible scheduling

Job summary

Scorpion Therapeutics in Boston is seeking a Biostatistics Associate Director to lead advanced statistical analyses for drug development in a biopharma setting. The role involves guiding statistical work across trials and real-world data projects, authoring SAPs, and contributing to regulatory interactions.

The candidate should hold a PhD in Statistics or Biostatistics with 7+ years of experience, expert SAS and R skills, and prior staff management experience is preferred.

Qualifications

• Requires PhD in Statistics or Biostatistics and 7+ years of experience.
• Expertise in SAS and R.
• Extensive knowledge of statistical methods in drug development.
• Prior staff management experience preferred.

Responsibilities

• Lead statistical work for multiple clinical trials or real-world data investigations.
• Author study SAPs and contribute to CSRs.
• Develop novel analysis methods and contribute to methodological publications.
• Collaborate on regulatory interactions and represent biostatistics in cross-functional teams.
• Review programming specifications.

Skills

SAS

R

Education

PhD in Statistics or Biostatistics

Job description

Role:

Biostatistics Associate Director providing advanced statistical analyses to support drug development in a biopharma setting.

Responsibilities:

lead statistical work for multiple clinical trials or RWD investigations, author study SAPs, contribute to CSRs, develop analysis methods, and collaborate on regulatory interactions. Represent biostatistics in cross-functional teams, review programming specifications, and contribute to methodological publications.

Requirements:

Ph.D. in Statistics or Biostatistics with 7+ years of experience; expertise in SAS and R; extensive knowledge of statistical methods in drug development; prior staff management experience preferred.

High-Value:

involvement in NDA/MAA processes, direct engagement with regulators, global medicines development, and a hybrid/onsite work setup with flexible scheduling.